Search...
CHINARES PHARMA: China Resources Boya Bio's net profit for the first three quarters is 343 million yuan, a year-on-year decrease of 16.8%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, CHINARES PHARMA announced that China Resources BoYa Biotechnology achieved a total operating revenue of RMB 1.474 billion for the nine months ending September 30, 2025, an increase of 18.4% year-on-year; net profit was RMB 343 million, a decrease of 16.8% year-on-year
According to the announcement from the Zhitong Finance APP, CHINARES PHARMA (03320) reported that China Resources Boya Biotechnology achieved a total operating revenue of RMB 1.474 billion for the nine months ending September 30, 2025, an increase of 18.4% year-on-year; net profit was RMB 343 million, a decrease of 16.8% year-on-year
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments